4F decreases IRF5 expression and activation in hearts of tight skin mice.
The apoAI mimetic 4F was designed to inhibit atherosclerosis by improving HDL. We reported that treating tight skin (Tsk(-/+)) mice, a model of systemic sclerosis (SSc), with 4F decreases inflammation and restores angiogenic potential in Tsk(-/+) hearts. Interferon regulating factor 5 (IRF5) is impo...
Main Authors: | Hao Xu, John G Krolikowski, Deron W Jones, Zhi-Dong Ge, Paul S Pagel, Kirkwood A Pritchard, Dorothée Weihrauch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3522636?pdf=render |
Similar Items
-
An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice.
by: Dorothee Weihrauch, et al.
Published: (2016-01-01) -
Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice1[S]
by: Hao Zhang, et al.
Published: (2013-11-01) -
Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model.
by: Mesias Pedroza, et al.
Published: (2017-01-01) -
Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice
by: Momoko Nakao, et al.
Published: (2020-05-01) -
N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor1[S]
by: Hao Zhang, et al.
Published: (2013-11-01)